Skip to main content
Top
Published in: Clinical Oral Investigations 3/2015

01-04-2015 | Original Article

Aberrant expression of p-Smad3 in oral carcinogenesis

Authors: Sopee Poomsawat, Jirapa Punyasingh, Paisarn Vejchapipat

Published in: Clinical Oral Investigations | Issue 3/2015

Login to get access

Abstract

Objective

Smads are the keys of transforming growth factor β (TGFβ) signaling cascade and play a crucial role in many cancers. Once TGFβ receptors are activated, Smad2 and Smad3 are phosphorylated and form complexes with Smad4. These complexes translocate from the cytoplasm to the nucleus where they regulate the target genes. The subcellular localization of phosphorylated Smad3 (p-Smad3) in oral carcinogenesis has never been reported. This study investigated the subcellular distribution of p-Smad3 in oral squamous cell carcinoma (OSCC) and oral leukoplakia (OL) with and without dysplasia.

Materials and methods

Expression of p-Smad3 was immunohistochemically examined in 150 samples including OSCC, OL with and without dysplasia, and normal mucosa (NM). Cytoplasmic and nuclear positive cells were counted separately. The results were present as the frequency of positive cases.

Results

Cytoplasmic and/or nuclear staining for p-Smad3 was detected. The frequency of cytoplasmic expression in OL with dysplasia was significantly higher than that in NM. The numbers of cytoplasmic expression and cytoplasmic plus nuclear expression in OSCC were significantly higher than those in NM and OL with and without dysplasia.

Conclusions

The overexpression of cytoplasmic p-Smad3 in OL with dysplasia and in OSCC suggests that p-Smad3 is in the nonfunctional state. Thus, the growth inhibitory effect of p-Smad3 is diminished during oral carcinogenesis. The cytoplasmic plus nuclear staining of p-Smad3 was aberrant in OSCC.

Clinical relevance

The cytoplasmic staining of p-Smad3 may serve as a marker for oral premalignant lesions whereas the cytoplasmic plus nuclear staining of p-Smad3 may serve as a marker for OSCC.
Literature
1.
3.
go back to reference Chen YK, Huang AH, Cheng PH, Yang SH, Lin LM (2013) Overexpression of Smad proteins, especially Smad7, in oral epithelial dysplasias. Clin Oral Invest 17:921–932CrossRef Chen YK, Huang AH, Cheng PH, Yang SH, Lin LM (2013) Overexpression of Smad proteins, especially Smad7, in oral epithelial dysplasias. Clin Oral Invest 17:921–932CrossRef
4.
go back to reference Friedman E, Gold LI, Klimstra D, Zeng ZS, Winawer S, Cohen A (1995) High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer. Cancer Epidemiol Biomarkers Prev 4:549–554PubMed Friedman E, Gold LI, Klimstra D, Zeng ZS, Winawer S, Cohen A (1995) High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer. Cancer Epidemiol Biomarkers Prev 4:549–554PubMed
5.
go back to reference Friess H, Yamanaka Y, Buchler M et al (1993) Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 105:1846–1856PubMed Friess H, Yamanaka Y, Buchler M et al (1993) Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 105:1846–1856PubMed
6.
go back to reference Kim SH, Ahn S, Park CK (2012) Smad3 and its phosphoisoforms are prognostic predictors of hepatocellular carcinoma after curative hepatectomy. Hepatobiliary Pancreat Dis Int 11:51–59CrossRefPubMed Kim SH, Ahn S, Park CK (2012) Smad3 and its phosphoisoforms are prognostic predictors of hepatocellular carcinoma after curative hepatectomy. Hepatobiliary Pancreat Dis Int 11:51–59CrossRefPubMed
7.
go back to reference Korchynskyi O, Landstrom M, Stoika R et al (1999) Expression of Smad proteins in human colorectal cancer. Int J Cancer 82:197–202CrossRefPubMed Korchynskyi O, Landstrom M, Stoika R et al (1999) Expression of Smad proteins in human colorectal cancer. Int J Cancer 82:197–202CrossRefPubMed
8.
go back to reference Lu SL, Reh D, Li AG et al (2004) Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation. Cancer Res 64:4405–4410CrossRefPubMed Lu SL, Reh D, Li AG et al (2004) Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation. Cancer Res 64:4405–4410CrossRefPubMed
9.
go back to reference Paterson IC, Matthews JB, Huntley S et al (2001) Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma. J Pathol 193:458–467CrossRefPubMed Paterson IC, Matthews JB, Huntley S et al (2001) Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma. J Pathol 193:458–467CrossRefPubMed
10.
go back to reference Xie W, Aisner S, Baredes S, Sreepada G, Shah R, Reiss M (2013) Alterations of Smad expression and activation in defining 2 subtypes of human head and neck squamous cell carcinoma. Head Neck 35:76–85CrossRefPubMed Xie W, Aisner S, Baredes S, Sreepada G, Shah R, Reiss M (2013) Alterations of Smad expression and activation in defining 2 subtypes of human head and neck squamous cell carcinoma. Head Neck 35:76–85CrossRefPubMed
11.
go back to reference Danielsson K, Wahlin YB, Coates PJ, Nylander K (2010) Increased expression of Smad proteins, and in particular Smad3, in oral lichen planus compared to normal oral mucosa. J Oral Pathol Med 39:639–644CrossRefPubMed Danielsson K, Wahlin YB, Coates PJ, Nylander K (2010) Increased expression of Smad proteins, and in particular Smad3, in oral lichen planus compared to normal oral mucosa. J Oral Pathol Med 39:639–644CrossRefPubMed
12.
go back to reference Kawamata S, Matsuzaki K, Murata M et al (2011) Oncogenic Smad3 signaling induced by chronic inflammation is an early event in ulcerative colitis-associated carcinogenesis. Inflamm Bowel Dis 17:683–695CrossRefPubMed Kawamata S, Matsuzaki K, Murata M et al (2011) Oncogenic Smad3 signaling induced by chronic inflammation is an early event in ulcerative colitis-associated carcinogenesis. Inflamm Bowel Dis 17:683–695CrossRefPubMed
13.
go back to reference Cuffari L, Tesseroli de Siqueira JT, Nemr K, Rapaport A (2006) Pain complaint as the first symptom of oral cancer: a descriptive study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:56–61CrossRefPubMed Cuffari L, Tesseroli de Siqueira JT, Nemr K, Rapaport A (2006) Pain complaint as the first symptom of oral cancer: a descriptive study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:56–61CrossRefPubMed
14.
go back to reference Barnes L, Eveson JW, Reichart P, Sidransky D (2005) World Health Organization classification of tumours of head and neck, Lyon Barnes L, Eveson JW, Reichart P, Sidransky D (2005) World Health Organization classification of tumours of head and neck, Lyon
15.
go back to reference Axell T, Pindborg JJ, Smith CJ, van der Waal I (1996) Oral white lesions with special reference to precancerous and tobacco- related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med 25:49–54CrossRefPubMed Axell T, Pindborg JJ, Smith CJ, van der Waal I (1996) Oral white lesions with special reference to precancerous and tobacco- related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med 25:49–54CrossRefPubMed
16.
go back to reference Poomsawat S, Buajeeb W, Khovidhunkit SO, Punyasingh J (2010) Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions. J Oral Pathol Med 39:793–799CrossRefPubMed Poomsawat S, Buajeeb W, Khovidhunkit SO, Punyasingh J (2010) Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions. J Oral Pathol Med 39:793–799CrossRefPubMed
17.
go back to reference Tian F, DaCosta Byfield S, Parks WT et al (2003) Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Cancer Res 63:8284–8292PubMed Tian F, DaCosta Byfield S, Parks WT et al (2003) Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Cancer Res 63:8284–8292PubMed
18.
go back to reference He W, Cao T, Smith DA, Myers TE, Wang XJ (2001) Smads mediate signaling of the TGFbeta superfamily in normal keratinocytes but are lost during skin chemical carcinogenesis. Oncogene 20:471–483CrossRefPubMed He W, Cao T, Smith DA, Myers TE, Wang XJ (2001) Smads mediate signaling of the TGFbeta superfamily in normal keratinocytes but are lost during skin chemical carcinogenesis. Oncogene 20:471–483CrossRefPubMed
20.
go back to reference Matsuura I, Denissova NG, Wang G, He D, Long J, Liu F (2004) Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 430:226–231CrossRefPubMed Matsuura I, Denissova NG, Wang G, He D, Long J, Liu F (2004) Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 430:226–231CrossRefPubMed
21.
go back to reference Liu F, Matsuura I (2005) Inhibition of Smad antiproliferative function by CDK phosphorylation. Cell Cycle 4:63–66CrossRefPubMed Liu F, Matsuura I (2005) Inhibition of Smad antiproliferative function by CDK phosphorylation. Cell Cycle 4:63–66CrossRefPubMed
22.
go back to reference Chen Q, Luo G, Li B, Samaranayake LP (1999) Expression of p16 and CDK4 in oral premalignant lesions and oral squamous cell carcinomas: a semi-quantitative immunohistochemical study. J Oral Pathol Med 28:158–164CrossRefPubMed Chen Q, Luo G, Li B, Samaranayake LP (1999) Expression of p16 and CDK4 in oral premalignant lesions and oral squamous cell carcinomas: a semi-quantitative immunohistochemical study. J Oral Pathol Med 28:158–164CrossRefPubMed
23.
go back to reference Leivonen SK, Ala-Aho R, Koli K, Grenman R, Peltonen J, Kahari VM (2006) Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells. Oncogene 25:2588–2600CrossRefPubMed Leivonen SK, Ala-Aho R, Koli K, Grenman R, Peltonen J, Kahari VM (2006) Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells. Oncogene 25:2588–2600CrossRefPubMed
24.
go back to reference Fynan TM, Reiss M (1993) Resistance to inhibition of cell growth by transforming growth factor-beta and its role in oncogenesis. Crit Rev Oncog 4:493–540PubMed Fynan TM, Reiss M (1993) Resistance to inhibition of cell growth by transforming growth factor-beta and its role in oncogenesis. Crit Rev Oncog 4:493–540PubMed
25.
go back to reference Reiss M, Stash EB (1990) High frequency of resistance of human squamous carcinoma cells to the anti-proliferative action of transforming growth factor beta. Cancer Commun 2:363–369PubMed Reiss M, Stash EB (1990) High frequency of resistance of human squamous carcinoma cells to the anti-proliferative action of transforming growth factor beta. Cancer Commun 2:363–369PubMed
27.
go back to reference Inman GJ, Nicolas FJ, Hill CS (2002) Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. Mol Cell 10:283–294CrossRefPubMed Inman GJ, Nicolas FJ, Hill CS (2002) Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. Mol Cell 10:283–294CrossRefPubMed
Metadata
Title
Aberrant expression of p-Smad3 in oral carcinogenesis
Authors
Sopee Poomsawat
Jirapa Punyasingh
Paisarn Vejchapipat
Publication date
01-04-2015
Publisher
Springer Berlin Heidelberg
Published in
Clinical Oral Investigations / Issue 3/2015
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-014-1281-7

Other articles of this Issue 3/2015

Clinical Oral Investigations 3/2015 Go to the issue